Suppr超能文献

大鼠体内缺血/再灌注心肌中丝裂原活化蛋白激酶的激活

Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats.

作者信息

Omura T, Yoshiyama M, Shimada T, Shimizu N, Kim S, Iwao H, Takeuchi K, Yoshikawa J

机构信息

First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan.

出版信息

J Mol Cell Cardiol. 1999 Jun;31(6):1269-79. doi: 10.1006/jmcc.1999.0959.

Abstract

In this study, we investigate the in vivo activation of mitogen-activated protein kinases (MAPK) as important signal transduction cascades observed after myocardial ischemia/reperfusion. Myocardial continuous ischemia and ischemia/reperfusion was produced in Wistar rats. The activities of MAPKs in the ischemic and ischemia/reperfused regions were measured using an in-gel kinase assay, an in vitro kinase assay and Western blot analysis. Activator protein-1 (AP-1) DNA binding activity was determined using an electrophoretic mobility shift assay. DNA fragmentation was detected as DNA ladders by agarose gel electrophoresis. The p46JNK and p55JNK activities of continuous ischemia were significantly increased at 30 min (5.9 and 4.2 fold, respectively P<0.05). Coronary reperfusion increased both p42ERK and p44ERK activities at 30 min (3.0 and 2.3 fold P<0.01), and both p46JNK and p55JNK activities at 30 min (1.4 and 1.7 fold P<0.05). The AP-1 DNA binding activities of continuous ischemia were significantly increased at 1, 3 and 7 days (28, 21 and 17 fold, respectively P<0.01). Coronary reperfusion markedly decreased AP-1 DNA binding activities at 1 (41%P<0.01) and 3 days (48%P<0.05). Myocardial DNA fragmentation was considerably more enhanced by reperfusion than continuous ischemia. In conclusion, our present work provides the first in vivo evidence that ERK and JNK are activated by reperfusion from the activities of continuous ischemia. These signal transduction mechanisms may be partially responsible for the myocardial injury.

摘要

在本研究中,我们探究了丝裂原活化蛋白激酶(MAPK)作为心肌缺血/再灌注后观察到的重要信号转导级联反应的体内激活情况。在Wistar大鼠中制造心肌持续缺血和缺血/再灌注模型。使用凝胶内激酶测定法、体外激酶测定法和蛋白质免疫印迹分析来测量缺血和缺血/再灌注区域中MAPK的活性。使用电泳迁移率变动分析来测定活化蛋白-1(AP-1)的DNA结合活性。通过琼脂糖凝胶电泳将DNA片段检测为DNA梯带。持续缺血30分钟时,p46JNK和p55JNK的活性显著增加(分别为5.9倍和4.2倍,P<0.05)。冠状动脉再灌注使30分钟时p42ERK和p44ERK的活性均增加(分别为3.0倍和2.3倍,P<0.01),同时也使30分钟时p46JNK和p55JNK的活性增加(分别为1.4倍和1.7倍,P<0.05)。持续缺血1、3和7天时,AP-1的DNA结合活性显著增加(分别为28倍、21倍和17倍,P<0.01)。冠状动脉再灌注使1天(降低41%,P<0.01)和3天(降低48%,P<0.05)时的AP-1 DNA结合活性显著降低。与持续缺血相比,再灌注使心肌DNA片段化明显增强。总之,我们目前的工作首次提供了体内证据,表明ERK和JNK在持续缺血的基础上被再灌注激活。这些信号转导机制可能部分导致心肌损伤。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验